Filing Flows › GE HealthCare Technologies (GEHC) › Capital expenditures
GE HealthCare Technologies (GEHC) capital expenditures by quarter
GE HealthCare Technologies' capital expenditures were $114M in Q3 2026 (third quarter 2026), +14% from Q2 2026. Over the last 7 quarters it ranged from $86.0M (Q2 2025) to $178M (Q1 2026).
| Quarter | Capital expenditures | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2026 | $114M | +14% | +4% |
| Q2 2026 | $100M | -44% | +16% |
| Q1 2026 | $178M | +33% | +17% |
| Q4 2025 | $134M | +22% | — |
| Q3 2025 | $110M | +28% | — |
| Q2 2025 | $86.0M | -43% | — |
| Q1 2025 | $152M | — | — |
Q3 2026 at a glance
GE HealthCare Technologies, Q3 2026: revenue $5.5B (+7% year over year), operating margin 14.6%, net earnings $615M, operating cash flow $907M. The chart follows the revenue to costs, profit and cash.
Questions
What is GE HealthCare Technologies' capital expenditures?
GE HealthCare Technologies' capital expenditures were $114M in Q3 2026 (third quarter 2026), +14% from Q2 2026.
How has GE HealthCare Technologies' capital expenditures changed?
Over the last 7 quarters it ranged from $86.0M (Q2 2025) to $178M (Q1 2026).
Q3 2026 results → · How GE HealthCare Technologies makes money →